BioSpace News Archive

Pharm Country

Trevi Therapeutics to Present at Upcoming August Conferences

Trevi Therapeutics, Inc. today announced it will be presenting at the following investor and medical meeting conferences.

August 9, 2022
·
2 min read
Genetown

BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference

BIONIK Laboratories Corp. today announced that Rich Russo, Chief Financial Officer and Interim Chief Executive Officer, will be presenting a corporate overview and meeting with institutional investors at the Q3 Virtual Investor Summit.

August 9, 2022
·
1 min read
Business

908 Devices Reports Second Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook

908 Devices Inc. today reported financial results for the quarter ended June 30, 2022.

August 9, 2022
·
7 min read
Business

Appia Bio Appoints Margo Roberts, Ph.D. to its Board of Directors and Names Jason Damiano, Ph.D. as Chief Scientific Officer

Appia Bio, Inc. today announced the appointment of Margo Roberts, Ph.D. to its board of directors and Jason Damiano, Ph.D. as chief scientific officer (CSO).

August 9, 2022
·
4 min read
Business

Rubius Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Rubius Therapeutics, Inc. (Nasdaq: RUBY), today reported second quarter 2022 financial results and provided a business update.

August 9, 2022
·
14 min read
Business

Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022

Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live audio webcast on Wednesday, August 10, 2022 at 4:30 p.m. ET to report its second quarter 2022 financial results and provide an update on its business and pipeline.

August 9, 2022
·
1 min read
Business

Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Black Diamond Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update.

August 9, 2022
·
8 min read
Business

Vivos Therapeutics Schedules Second Quarter 2022 Financial Results Conference CallCall Scheduled for Monday, August 15, 2022 at 5:00 pm ET

Vivos Therapeutics, Inc. today announced that it plans to release financial results for the second quarter ended June 30, 2022 after market close on Monday, August 15, 2022.

August 9, 2022
·
3 min read
Business

Daré Bioscience Reports Second Quarter 2022 Financial Results and Provides a Company Update

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended June 30, 2022 and provided a company update.

August 9, 2022
·
14 min read
Business

Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by brain disorders, today reported financial results and corporate highlights for the second quarter ended June 30, 2022.

August 9, 2022
·
8 min read